Fundz

VenstraMedical secures funding from Highcroft Capital to advance its next-generation cardiac support device.

PRIVATENov 18, 2025

Round Type

Funding Round

NewcastleBiotechnologyHealth CareMedicalMedical Device

Investors

Highcroft Capital

Description

VenstraMedical has announced an investment from Highcroft Capital to enhance the development of its percutaneous ventricular assist device (pVAD). This technology aims to improve cardiac care by offering complete ventricular unloading for patients in critical conditions. The funding will help accelerate their path to clinical trials. VenstraMedical's pVAD system is designed for minimally invasive insertion and is protected by eight patents.

Quick answer

Venstra Medical raised an undisclosed amount in a Funding Round round, dated November 18, 2025. Investors: Highcroft Capital. Venstra Medical is based in Newcastle, New South Wales, Australia.

How much did Venstra Medical raise?
Venstra Medical raised an undisclosed amount in a Funding Round round on November 18, 2025.
Who invested in Venstra Medical?
Highcroft Capital is named as investors in this round.
What does Venstra Medical do?
Venstra Medical is an Australian start-up that has developed the world’s smallest and most powerful percutaneous ventricular assist device (pVAD) for treating cardiogenic shock.
Where is Venstra Medical based and how big is it?
Venstra Medical is based in Newcastle, New South Wales, Australia. Fundz records about 4 employees.
Who are the decision-makers at Venstra Medical?
Fundz holds 1 contact at Venstra Medical. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Medical Device around the same time

Companies in the same sectors as Venstra Medical that raised within 45 days of this round, from Fundz verified event records.

  • Biobeat Technologies raised $50M (Series B) on December 30, 2025.
  • FONAR raised $10M on December 23, 2025.
  • FONAR raised $41M on December 23, 2025.
  • Uncovr raised $5.1M on December 11, 2025.
  • Subsense raised $10M (Funding Round) on December 11, 2025.
  • Kestra Medical Technologies raised $159M (Post-IPO Equity) on December 4, 2025.

Who to call at Venstra Medical, and when

A new round usually means Venstra Medical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Venstra Medical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Venstra Medical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Venstra Medical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Venstra Medical

Location

Newcastle, New South Wales, Australia

About

Venstra Medical is an Australian start-up that has developed the world’s smallest and most powerful percutaneous ventricular assist device (pVAD) for treating cardiogenic shock. The company's innovative heart pump aims to improve outcomes for smaller patients, particularly women, by addressing the limitations of existing pumps. Founded in 2018, Venstra Medical integrates its patented technology to disrupt a $1.5 billion market currently dominated by a single competitor. Their mission is to save more lives with a more effective cardiovascular device.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Venstra Medical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Venstra Medical's next move

See what Strategic adds

Venstra Medical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.